Back

dr. J.R.N. (Jochem) van der Voort van Zyp

dr. J.R.N. (Jochem) van der Voort van Zyp

Associate Professor - medical
  • Department of Radiotherapy

Research Programs

Research Output (105)

MRI-guided radiotherapy in twenty fractions for localised prostate cancer:results from the MOMENTUM study

Sritharan Kobika, Daamen Lois, Pathmanathan Angela, Schytte Tine, Pos Floris, Choudhury Ananya, van der Voort van Zyp Jochem R N, Kerkmeijer Linda G W, Hall William, Hall Emma, Verkooijen Helena M, Herbert Trina, Hafeez Shaista, Mitchell Adam, Tree Alison C May 2024, In: Clinical and translational radiation oncology. 46 9 p.

Automated pelvic MRI measurements associated with urinary incontinence for prostate cancer patients undergoing radical prostatectomy

van den Berg Ingeborg, Spaans Robert N, Wessels Frank J, van der Hoeven Erik J R J, Nolthenius Charlotte J Tutein, van den Bergh Roderick C N, van der Voort van Zyp Jochem R N, van den Berg Cornelis A T, van Melick Harm H E 2 Jan 2024, In: European radiology experimental. 8 10 p.

The Development and External Validation of Artificial Intelligence-Driven MRI-Based Models to Improve Prediction of Lesion-Specific Extraprostatic Extension in Patients with Prostate Cancer

van den Berg Ingeborg, Soeterik Timo F W, van der Hoeven Erik J R J, Claassen Bart, Brink Wyger M, Baas Diederik J H, Sedelaar J P Michiel, Heine Lizette, Tol Jim, van der Voort van Zyp Jochem R N, van den Berg Cornelis A T, van den Bergh Roderick C N, van Basten Jean-Paul A, van Melick Harm H E 17 Nov 2023, In: Cancers. 15 10 p.

In response to Grivas et al

van den Berg Ingeborg, Savenije Mark H.F., Teunissen Frederik R., van de Pol Sandrine M.G., Rasing Marnix J.A., van Melick Harm H.E., Brink Wyger M., de Boer Johannes C.J., van den Berg Cornelis A.T., van der Voort van Zyp Jochem R.N. Oct 2023, In: Physics and Imaging in Radiation Oncology. 28 1 p.

Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability

Sritharan K, Akhiat A, Cahill D, Choi S, Choudhury A, Chung P, Diaz J, Dysager L, Hall W, Huddart R, Kerkmeijer L G W, Lawton C, Mohajer J, Murray J, Nyborg C J, Pos F J, Rigo M, Schytte T, Sidhom M, Sohaib A, Tan A, van der Voort van Zyp J, Vesprini D, Zelefsky M J, Tree A C 24 Aug 2023, In: International journal of radiation oncology, biology, physics. 118 , p. 378-389 12 p.

Realizing the value of complex medical technology:Demonstrating cost-effectiveness is not enough

Hehakaya C., Frederix G. W.J., van der Voort van Zyp J. RN, Grobbee D. E., Verkooijen H. M. Jul 2023, In: Clinical and translational radiation oncology. 41

Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer

Reesink Daan J., van Melick Harm H.E., van der Nat Paul B., Los Maartje, Horenblas Simon, van de Garde Ewoudt M.W., Biesma D. H., Stijns P. E.F., Lavalaye J., De Bruin P. C., Peters B. J.M., Somford D. M., Berends M., Richardson R., Van Andel G., Klaver O. S., Haberkorn B. C.M., Van Rooijen J. M., Korthorst R. A., Meijer R. P., Van der Voort Van Zyp J. R.N., Jun 2023, In: World Journal of Urology. 41 , p. 1551-1562 12 p.

From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting:Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial

De Cock Lisa, Draulans Cédric, Pos Floris J, Isebaert Sofie, De Roover Robin, van der Heide Uulke A, Smeenk Robert J, Kunze-Busch Martina, van der Voort van Zyp Jochem, de Boer Hans, Kerkmeijer Linda G W, Haustermans Karin 11 May 2023, In: Radiotherapy & Oncology. 185

Deep learning for automated contouring of neurovascular structures on magnetic resonance imaging for prostate cancer patients

van den Berg Ingeborg, Savenije Mark H F, Teunissen Frederik R, van de Pol Sandrine M G, Rasing Marnix J A, van Melick Harm H E, Brink Wyger M, de Boer Johannes C J, van den Berg Cornelis A T, van der Voort van Zyp Jochem R N Apr 2023, In: Physics and Imaging in Radiation Oncology. 26

Tolerability of concurrent external beam radiotherapy and [ 177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial).

van der Sar Esmée C A, Braat Arthur J A T, van der Voort-van Zyp Jochem R N, van der Veen Betty S, van Leeuwen Pim J, de Vries-Huizing Daphne M V, Hendrikx Jeroen M A, Lam Marnix G E H, Vogel Wouter V 23 Mar 2023, In: BMC Cancer. 23

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not